Scott D. Sandell - Jan 29, 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
10%+ Owner
Signature
/s/ Stephanie Brecher, attorney-in-fact
Stock symbol
SGMT
Transactions as of
Jan 29, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 05:00 PM
Previous filing
Dec 21, 2023
Next filing
Apr 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Other $0 -850K -22.08% $0.00 3M Jan 29, 2024 See Note 2 F1, F2
transaction SGMT Series A Common Stock Other $0 +261K $0.00 261K Jan 29, 2024 See Note 4 F3, F4
transaction SGMT Series A Common Stock Other $0 -261K -100% $0.00* 0 Jan 29, 2024 See Note 4 F4, F5
transaction SGMT Series A Common Stock Other $0 +7K $0.00 7K Jan 29, 2024 See Note 7 F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Scott D. Sandell is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution of 850,000 shares of Series A Common Stock of the Issuer to its general partner and limited partners for no consideration on January 29, 2024.
F2 The Reporting Person is a director of NEA 13 GP, LTD ("NEA 13 LTD"), which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of NEA 13, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 13 in which the Reporting Person has no pecuniary interest.
F3 NEA Partners 13 received 260,950 shares of Series A Common Stock of the Issuer in the distribution made by NEA 13 on January 29, 2024.
F4 The Reporting Person is a director of NEA 13 LTD, the sole general partner of NEA Partners 13, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 13 in which the Reporting Person has no pecuniary interest.
F5 NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 260,950 shares of Series A Common Stock of the Issuer to its limited partners on January 29, 2024.
F6 The Reporting Person, as Trustee of the Blue Mountain Trust, dated April 29, 2019 (the "Blue Mountain Trust") received 6,997 shares of Series A Common Stock of the Issuer in the distribution by NEA Partners 13 on January 29, 2024.
F7 The Reporting Person is Trustee of the Blue Mountain Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Blue Mountain Trust in which the Reporting Person has no pecuniary interest.